Largest pharmaceutical companies in the United States by total assets
Everything the company owns, as its balance sheet stood at the end of the latest fiscal year.
Pfizer leads the 44 pharmaceutical companies in the United States ranked by total assets, at DKK 1.42T, ahead of Johnson & Johnson (DKK 1.35T) and Merck & Co (DKK 930.8B). Figures as of 20 Nov 2026, 12:56 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 44
- First
- PfizerDKK 1.42T
- Median
- DKK 10.2B
- Combined market value
- DKK 25.41T
- Countries
- 1
Market values as of .
United States▾
All sectors▾
Pharmaceuticals▾
| # | Company | Total assets ↓ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | PfizerPFE · Health Care | DKK 1.42T | DKK 1.07T | DKK 187.29 | 1.85% down | 10% up | ||
| 2 | Johnson & JohnsonJNJ · Health Care | DKK 1.35T | DKK 4.37T | DKK 1,816.70 | 2.04% down | 31% up | ||
| 3 | Merck & CoMRK · Health Care | DKK 930.8B | DKK 2.23T | DKK 903.18 | 3.61% down | 36% up | ||
| 4 | AbbVieABBV · Health Care | DKK 911B | DKK 3.41T | DKK 1,928.23 | 0.86% down | 20% up | ||
| 5 | Eli LillyLLY · Health Care | DKK 764.9B | DKK 8.18T | DKK 9,188.35 | 2.29% down | 28% up | ||
| 6 | Bristol-Myers SquibbBMY · Health Care | DKK 612.3B | DKK 811B | DKK 396.74 | 2.05% down | 26% up | ||
| 7 | Abbott LaboratoriesABT · Health Care | DKK 589.7B | DKK 1.22T | DKK 706.37 | 0.58% down | 19% down | ||
| 8 | Regeneron PharmaceuticalsREGN · Health Care | DKK 275.8B | DKK 649.6B | DKK 6,279.21 | 2.35% down | 22% up | ||
| 9 | ViatrisVTRS · Health Care | DKK 252.9B | DKK 155B | DKK 135.19 | 1.97% down | 90% up | ||
| 10 | Vertex PharmaceuticalsVRTX · Health Care | DKK 174.4B | DKK 897.7B | DKK 3,540.77 | 2.94% down | 22% up | ||
| 11 | Royalty PharmaRPRX · Health Care | DKK 133.4B | DKK 264.8B | DKK 460.53 | 1.38% down | 74% up | ||
| 12 | ZoetisZTS · Health Care | DKK 105.2B | DKK 223.2B | DKK 549.42 | 5.59% down | 34% down | ||
| 13 | Elanco Animal HealthELAN · Health Care | DKK 90.8B | DKK 89.4B | DKK 178.79 | 1.54% down | 18% up | ||
| 14 | United TherapeuticsUTHR · Health Care | DKK 53.6B | DKK 161.9B | DKK 3,802.18 | 3.16% down | 18% up | ||
| 15 | BioMarin PharmaceuticalBMRN · Health Care | DKK 51.6B | DKK 80.9B | DKK 417.69 | 0.02% down | 12% up | ||
| 16 | Alnylam PharmaceuticalsALNY · Health Care | DKK 33.8B | DKK 134.6B | DKK 1,005.26 | 1.06% down | 66% down | ||
| 17 | Amneal PharmaceuticalsAMRX · Health Care | DKK 25B | DKK 50.7B | DKK 145.46 | 2.24% down | 79% up | ||
| 18 | Ionis PharmaceuticalsIONS · Health Care | DKK 24B | DKK 30.8B | DKK 185.11 | 0.62% down | 64% down | ||
| 19 | PTC TherapeuticsPTCT · Health Care | DKK 19.7B | DKK 33.1B | DKK 396.64 | 3.16% down | 26% down | ||
| 20 | InsmedINSM · Health Care | DKK 15.4B | DKK 215.5B | DKK 982.41 | 20.58% up | 27% down | ||
| 21 | Legend BiotechLEGN · Health Care | DKK 11.8B | DKK 21.2B | DKK 109.49 | 0.92% down | 43% down | ||
| 22 | Ligand PharmaceuticalsLGND · Health Care | DKK 10.6B | DKK 39B | DKK 1,951.35 | 3.94% down | 44% up | ||
| 23 | CytokineticsCYTK · Health Care | DKK 9.7B | DKK 48.8B | DKK 349.96 | 0.27% up | 21% down | ||
| 24 | Arrowhead PharmaceuticalsARWR · Health Care | DKK 9.4B | DKK 42B | DKK 296.84 | 1.25% up | 8% up | ||
| 25 | Madrigal PharmaceuticalsMDGL · Health Care | DKK 8.6B | DKK 62.7B | DKK 2,698.05 | 0.34% down | 28% down | ||
| 26 | TG TherapeuticsTGTX · Health Care | DKK 7.2B | DKK 66.7B | DKK 441.22 | 1.88% down | 103% up | ||
| 27 | Praxis Precision MedicinesPRAX · Health Care | DKK 6.4B | DKK 59.1B | DKK 2,114.29 | 1.87% up | 83% up | ||
| 28 | Cogent BiosciencesCOGT · Health Care | DKK 6.4B | DKK 32.8B | DKK 188.65 | 0.25% down | 25% down | ||
| 29 | BridgeBio PharmaBBIO · Health Care | DKK 6.4B | DKK 103.6B | DKK 531.67 | 0.22% up | 15% up | ||
| 30 | Mirum PharmaceuticalsMIRM · Health Care | DKK 5.7B | DKK 42.4B | DKK 649.52 | 3.27% up | 35% up | ||
| 31 | Corcept TherapeuticsCORT · Health Care | DKK 5.7B | DKK 48.4B | DKK 441.90 | 4.15% down | 16% down | ||
| 32 | Belite BioBLTE · Health Care | DKK 5.3B | DKK 41.7B | DKK 1,027.02 | 3.33% down | 25% up | ||
| 33 | Spyre TherapeuticsSYRE · Health Care | DKK 5.3B | DKK 63.1B | DKK 663.94 | 3.77% down | 302% up | ||
| 34 | Summit TherapeuticsSMMT · Health Care | DKK 5.1B | DKK 57.5B | DKK 71.88 | 0.67% up | 35% down | ||
| 35 | Axsome TherapeuticsAXSM · Health Care | DKK 4.7B | DKK 48.5B | DKK 922.70 | 1.25% up | 9% down | ||
| 36 | Protagonist TherapeuticsPTGX · Health Care | DKK 4.5B | DKK 55B | DKK 843.40 | 2.47% down | 45% up | ||
| 37 | Travere TherapeuticsTVTX · Health Care | DKK 4.1B | DKK 31.5B | DKK 328.47 | 3.86% down | 39% up | ||
| 38 | Edgewise TherapeuticsEWTX · Health Care | DKK 3.8B | DKK 30.7B | DKK 279.98 | 0.48% down | 82% up | ||
| 39 | Dianthus TherapeuticsDNTH · Health Care | DKK 3.6B | DKK 32.5B | DKK 576.89 | 1.01% up | 105% up | ||
| 40 | Oruka TherapeuticsORKA · Health Care | DKK 3.3B | DKK 45B | DKK 663.53 | 1.91% up | 233% up | ||
| 41 | Rhythm PharmaceuticalsRYTM · Health Care | DKK 3.3B | DKK 55.1B | DKK 794.30 | 1.88% down | 15% up | ||
| 42 | Definium TherapeuticsDFTX · Health Care | DKK 3B | DKK 27.4B | DKK 200.48 | 1.24% up | 176% up | ||
| 43 | ErascaERAS · Health Care | DKK 2.7B | DKK 33.9B | DKK 96.70 | 3.34% up | 387% up | ||
| 44 | VeradermicsMANE · Health Care | DKK 1B | DKK 35.7B | DKK 845.92 | 0.38% down | 230% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Total assets is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Sums are converted from US dollars at today's exchange rate (1 USD = 6.8005 DKK).
Questions and answers
Which pharmaceutical companies in the United States rank first by total assets?
Pfizer (DKK 1.42T), Johnson & Johnson (DKK 1.35T) and Merck & Co (DKK 930.8B) are the top three of the 44 pharmaceutical companies in the United States ranked by total assets as of 20 Nov 2026, 12:56 UTC.
How many pharmaceutical companies in the United States are in this ranking?
44 are ranked by total assets.
What are these pharmaceutical companies in the United States worth together?
The 44 pharmaceutical companies in the United States ranked by total assets have a combined market value of DKK 25.41T as of 20 Nov 2026, 12:56 UTC.
What does ranking by total assets measure?
Everything the company owns, as its balance sheet stood at the end of the latest fiscal year.
Learn how this ranking works
All markets guides →- Altman Z-score: formula, zones and where it fails
The Altman Z-score is a weighted sum of five financial ratios that Edward Altman fitted in 1968 to separate companies that went bankrupt from those that did not. Funkfolio reads above 2.99 as the safe zone, below 1.81 as the distress zone, and between them a grey zone. It does not suit banks or insurers.
- Market cap vs enterprise value: what is the difference?
Market capitalization is the value of a company's shares. Enterprise value is market cap plus debt, minus cash: roughly what it would cost to buy the whole business and settle its borrowings. Two companies with the same $50 billion market cap can have very different enterprise values if one owes $20 billion and the other holds $20 billion in cash.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
Cite this page
Funkfolio, “Largest pharmaceutical companies in the United States by total assets”, data as of 20 November 2026. https://funkfolio.com/companies/category/pharmaceuticals?country=united-states&by=total-assets
Underlying data: Yahoo Finance; SEC EDGAR.